Tanush Gupta, MD
Interventional Cardiology · Burlington, VTNPI 1639413636
Payments from drug & device makers
Across 96 payments — averaging $284.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$19K
- Abbott$5K
- Edwards Lifesciences$3K
- Boston Scientific$515
- Abiomed$239
- Biotronik Inc.$30
- plus $17 from 1 others
What the payments were for
- Speaking & faculty fees$16,07659%
- Travel & lodging$6,82825%
- Food & beverage$3,89714%
- Education$4932%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 42 | $18,916 |
| Abbott | 31 | $4,647 |
| Edwards Lifesciences | 14 | $2,930 |
| Boston Scientific | 5 | $515 |
| Abiomed | 2 | $239 |
| Biotronik Inc. | 1 | $30 |
| Amgen | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$17,157
- EVOQUE$2,213
- MitraClip$1,982
- CoreValve Evolut$429
- MitraClip System$264
- Resolute$251
- APOLLOTM$214
- Ensite Cardiac Mapping System$212
- Telescope$171
- SYNERGY$140
- WATCHMAN Access System$121
- Xience Sierra Coronary Stent System$117
- HawkOne$111
- XIENCE SIERRA$105
How this compares
Too few interventional cardiology providers in Vermontto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 27 | $43,677 |
| JardianceEmpagliflozin | 33 | $29,394 |
| Praluent PenAlirocumab | 15 | $10,120 |
| Atorvastatin Calcium | 129 | $1,223 |
| Metoprolol Succinate | 84 | $1,123 |
| Spironolactone | 75 | $627 |
| Losartan Potassium | 37 | $540 |
| Rosuvastatin Calcium | 16 | $404 |
| Lisinopril | 49 | $321 |
| Amlodipine Besylate | 34 | $313 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $245 |
| ClopidogrelClopidogrel Bisulfate | 33 | $232 |
| Carvedilol | 17 | $220 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 12 | $213 |
| Hydrochlorothiazide | 17 | $70 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Burlington
- Jan DenkmannBurlington$5K
- Jesse KaneBurlington$3K
- Prospero GogoBurlington$894
- Magdalena ZeglinBurlington$343
- Kevin CareyBurlington$0
- Rony LahoudSouth Burlington$765K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.